HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by Narwhal Capital Management

Narwhal Capital Management reduced its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 46.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 10,450 shares of the company's stock after selling 9,056 shares during the period. Narwhal Capital Management's holdings in HCA Healthcare were worth $3,611,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in HCA. Brighton Jones LLC purchased a new position in HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Atria Wealth Solutions Inc. boosted its holdings in shares of HCA Healthcare by 28.6% in the fourth quarter. Atria Wealth Solutions Inc. now owns 4,256 shares of the company's stock valued at $1,277,000 after acquiring an additional 946 shares during the period. Private Advisor Group LLC boosted its holdings in shares of HCA Healthcare by 28.7% in the fourth quarter. Private Advisor Group LLC now owns 4,354 shares of the company's stock valued at $1,307,000 after acquiring an additional 972 shares during the period. Transcend Capital Advisors LLC boosted its holdings in shares of HCA Healthcare by 6.9% in the fourth quarter. Transcend Capital Advisors LLC now owns 1,310 shares of the company's stock valued at $393,000 after acquiring an additional 85 shares during the period. Finally, Sigma Planning Corp boosted its holdings in shares of HCA Healthcare by 25.9% in the fourth quarter. Sigma Planning Corp now owns 714 shares of the company's stock valued at $214,000 after acquiring an additional 147 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

Shares of HCA stock traded up $0.34 during mid-day trading on Tuesday, reaching $379.06. The stock had a trading volume of 1,103,292 shares, compared to its average volume of 1,469,726. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a market cap of $91.19 billion, a P/E ratio of 16.85, a price-to-earnings-growth ratio of 1.31 and a beta of 1.49. The business has a 50-day simple moving average of $363.94 and a 200 day simple moving average of $335.66. The company has a current ratio of 1.19, a quick ratio of 1.06 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 EPS for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. HCA Healthcare had a return on equity of 1,063.91% and a net margin of 8.07%. The firm's quarterly revenue was up 5.7% compared to the same quarter last year. During the same quarter last year, the business posted $5.36 EPS. On average, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.

Insider Buying and Selling

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares of the company's stock, valued at approximately $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on HCA. Barclays set a $416.00 price target on HCA Healthcare and gave the stock an "overweight" rating in a report on Monday, June 2nd. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the stock an "equal weight" rating in a report on Monday, June 9th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down from $396.00) on shares of HCA Healthcare in a report on Tuesday, April 15th. Stephens raised HCA Healthcare to a "strong-buy" rating in a report on Monday, June 2nd. Finally, Wells Fargo & Company upgraded HCA Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $320.00 to $385.00 in a research report on Thursday, May 29th. Seven investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $394.33.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.